Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SLN Silence Therapeutics > Detailed Quotes

SLN Silence Therapeutics

10.000
-0.300-2.91%
Trading Session 10/05 12:02 ET
High
10.860
Open
9.920
Turnover
410.88K
Low
9.700
Pre Close
10.300
Volume
40.27K
Market Cap
358.88M
P/E(TTM)
Loss
52wk High
26.840
Shares
35.89M
P/E(Static)
Loss
52wk Low
7.800
Float Cap
92.15M
Bid/Ask %
0.00%
Historical High
35.000
Shs Float
9.21M
Volume Ratio
1.51
Historical Low
7.800
Dividend TTM
--
Div Yield TTM
--
P/B
-66.67
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.44%
Amplitude
11.26%
Avg Price
10.203
Lot Size
1
Float Cap
92.15M
Bid/Ask %
0.00%
Historical High
35.000
Shs Float
9.21M
Volume Ratio
1.51
Historical Low
7.800
Dividend TTM
--
P/B
-66.67
Dividend LFY
--
Turnover Ratio
0.44%
Amplitude
11.26%
Avg Price
10.203
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
CEO: Mr. Craig A. Tooman
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...